Ringer's lactate solution

Assure Infusions Breaks Ground on Advanced Robotics Manufacturing Plant

Retrieved on: 
Tuesday, October 25, 2022
Medical Supplies, Medical Devices, Health, Manufacturing, Other Manufacturing, Pharmaceutical, Ringer's lactate solution, Hospital, IV, Robotics, Glucose, CEO, Multimedia, 3D printing, Medical device, Central Florida

Assure Infusions, Inc., joined by local elected officials and area economic development representatives, broke ground last week on the companys future fully-automated pharmaceutical manufacturing plant.

Key Points: 
  • Assure Infusions, Inc., joined by local elected officials and area economic development representatives, broke ground last week on the companys future fully-automated pharmaceutical manufacturing plant.
  • View the full release here: https://www.businesswire.com/news/home/20221025006077/en/
    Assure Infusions, Inc. broke ground on the company's future advanced robotics manufacturing plant in Central Florida.
  • With corporate offices in Winter Haven, Florida, the companys advanced robotics manufacturing plant will be in Bartow and will be operational in 2023.
  • Assure Infusions will play a critical role in ensuring that hospital demand for intravenous solutions is met with sufficient domestic manufacturing.

Assure Infusions to Build Pharmaceutical Manufacturing Facility in Central Florida

Retrieved on: 
Wednesday, August 3, 2022
Other Manufacturing, Technology, Medical Devices, Medical Supplies, Hospitals, Manufacturing, Other Health, Pharmaceutical, Robotics, Health, Ringer's lactate solution, Robotics, Â, Quality assurance, Glucose, CEO, Sleep, Hospital, Multimedia, Industry, IV, Founder, Acquisition, Medical device, Central Florida

Assure Infusions, Inc. , a new company that launched earlier this year to produce IV fluid products, is building a manufacturing plant in Bartow, Florida.

Key Points: 
  • Assure Infusions, Inc. , a new company that launched earlier this year to produce IV fluid products, is building a manufacturing plant in Bartow, Florida.
  • (Photo: Business Wire)
    Were excited to share our plans to build a state-of-the-art pharmaceutical manufacturing facility in Central Florida, said Alex Lucio, CEO of Assure Infusions.
  • Assure Infusions new facility will showcase the company as a highly-advanced, innovative new player in the pharmaceutical manufacturing industry.
  • Assure Infusions will play a critical role in ensuring that hospital demand for intravenous solutions is met with sufficient domestic manufacturing.

IV Therapy in Pasadena Now Offered by Muscle Lab

Retrieved on: 
Friday, January 7, 2022
Mitochondrion, Magnesium chloride, Electrolyte, Nail, Cocktail, Vitamin B12, Omicron, Biotin, Infection, Oral rehydration therapy, Potassium, Zinc, Skin, Weight loss, Amino acid, Patient, CA, Immune system, Heartburn, Goal, Life, Myer, Calcium chloride, Protein, Hair, Therapy, Immunity, Vitamin C, Ageing, Health, Ringer's lactate solution, B12, Vitamin, Virus, Solution, GLOBE, Myers' cocktail, Calcium gluconate, Lactate, Heart, Glutathione, IV, Medical device, Dietary supplement, Selenium, Sodium

Muscle Lab recently started to offer vitamin IV Therapy in their Pasadena location .

Key Points: 
  • Muscle Lab recently started to offer vitamin IV Therapy in their Pasadena location .
  • Los Angeles residents are eager to get an IV drip, and Muscle Lab has seen an increasing number of individuals wanting to try IV Therapy for their first time.
  • But now, IV Therapy is available to the general public to reap the benefits, the most popular being the hangover IV drip .
  • Muscle Lab's Pasadena location offers a wide range of vitamin IV Drips to choose from, depending on symptoms and goals.

Cybereason Exposes Iranian State-Sponsored Cyber Espionage Campaign Targeting Global Aerospace and Telecommunications Companies

Retrieved on: 
Wednesday, October 6, 2021
Cloud, EDR, Operation, Dropbox, Behavior, Collection, RAT, Command, Environment, Control, Ringer's lactate solution, Telemetry, Key finding attacks, Telecom, Intelligence, C2, XDR, Aerospace, Organization, Cybereason, APT, Advanced persistent threat, Remote desktop software, Weapon, Medical device, Cryptocurrency, Risk management

BOSTON, Oct. 6, 2021 /PRNewswire-PRWeb/ -- Cybereason , the leader in operation-centric attack protection, today published a new threat intelligence report that unmasks a highly-targeted cyber espionage operation targeting global aerospace and telecommunications companies.

Key Points: 
  • BOSTON, Oct. 6, 2021 /PRNewswire-PRWeb/ -- Cybereason , the leader in operation-centric attack protection, today published a new threat intelligence report that unmasks a highly-targeted cyber espionage operation targeting global aerospace and telecommunications companies.
  • The report, titled Operation GhostShell: Novel RAT Targets Global Aerospace and Telecoms Firms , details the stealthy attacks against companies in the Middle East, United States, Europe and Russia.
  • The investigation reveals possible connections to several Iranian state-sponsored threat actors including Chafer APT (APT39) and Agrius APT.
  • This report follows the August publication of the DeadRinger Report by Cybereason that similarly uncovered multiple Chinese APT campaigns targeting telecommunications providers.

Cybereason CEO Lior Div to Deliver Keynote at the Govware Conference

Retrieved on: 
Thursday, September 30, 2021
Government, EDR, Arbor Networks, CSO, CTO, McAfee, Div, EMC, Microsoft Exchange, Conference, Recipe, CA Technologies, SST, MicroStrategy, Threat actor, RSA Security, CEO, National, Security, Telecommunication, Ringer's lactate solution, GM, Medal of Honor: Allied Assault, The Security Institute, XDR, RSA, Security Division (Wehrmacht), Cybereason, SVP, Risk management, Cryptocurrency

BOSTON, Sept. 30, 2021 /PRNewswire-PRWeb/ -- Cybereason , the leader in operation-centric attack protection, today announced that Lior Div, CEO and co-founder, will be a keynote speaker at the Govware Conference , in Singapore, Wednesday, October 6, 9:30 am, SST.

Key Points: 
  • BOSTON, Sept. 30, 2021 /PRNewswire-PRWeb/ -- Cybereason , the leader in operation-centric attack protection, today announced that Lior Div, CEO and co-founder, will be a keynote speaker at the Govware Conference , in Singapore, Wednesday, October 6, 9:30 am, SST.
  • Div's keynote address will focus on Cybereason's year-long investigation into three Chinese threat groups that targeted telecommunications companies in Southeast Asia.
  • Prior to Cybereason, Div founded a cybersecurity services company that provided services to government agencies.
  • Cybereason is a privately held, international company headquartered in Boston with customers in more than 50 countries.

ICU Medical, Inc. Issues a Voluntary Nationwide Recall of Lactated Ringer's Injection, USP and 0.9% Sodium Chloride Injection, USP Due to Presence of Particulate Matter

Retrieved on: 
Wednesday, October 30, 2019
Medicine, Intravenous fluids, Clinical medicine, Health, RTT, Blood substitutes, Dosage forms, Ringer's lactate solution, Intravenous therapy, ICU Medical, Ringer, Chloride

LAKE FOREST, Ill., Oct. 30, 2019 /PRNewswire/ -- ICU Medical, Inc. (Nasdaq: ICUI)is voluntarily recalling one single lot of Lactated Ringer's Injection, USP, and one single lot of 0.9% Sodium Chloride Injection, USP.

Key Points: 
  • LAKE FOREST, Ill., Oct. 30, 2019 /PRNewswire/ -- ICU Medical, Inc. (Nasdaq: ICUI)is voluntarily recalling one single lot of Lactated Ringer's Injection, USP, and one single lot of 0.9% Sodium Chloride Injection, USP.
  • The products are being recalled to the hospital level due to the presence of particulate matter.
  • To date, ICU Medical, Inc. has not received reports of adverse events related to this recall.
  • Intravenous solutions containing sodium chloride are indicated for parenteral replenishment of fluid and sodium chloride as required by the clinical condition of the patient.